Work

In Silico Identification of a Potential Multi-Target Natural Compound Against Oral Cancer

Year: 2026
Type: article
Abstract: Oral cancer remains a significant global health problem due to delayed diagnosis and limited treatment effectiveness. This study employed an integrated in silico approach to identify potential natural compounds from the family Ganodermataceae, targeting chemokine receptors CXCR3, CXCR4 and CXCR7. A library of 1300 mushroom-derived compounds was screened using a ligand-based pharmacophore. The best hits were subjected to molecular docking. The computational candidate, (+)-Applanatumol D, was further evaluated using ADMET, DFT, 200 ns MD simulations and MM-GBSA. Molecular docking predicted interactions of (+)-Applanatumol D with all three receptors, ranging from −8.0 to −8.5 kcal/mol, with these values interpreted as relative computational docking scores rather than experimentally determined binding affinities. Molecular dynamics simulations showed receptor-dependent structural deviations, with greater deviations observed for the CXCR7 complex. ADMET predictions indicated favourable predicted drug-likeness characteristics, including high drug-likeness characteristics like high predicted gastrointestinal absorption alongside model-dependent toxicity predictions. Collectively, the results identify (+)-Applanatumol D as a promising multi-target computational candidate for further investigation against CXCR3, CXCR4, and CXCR7. The predicted interactions are consistent with potential receptor binding; however, whether (+)-Applanatumol D acts as an agonist or antagonist and its effects on receptor expression and oral cancer phenotypes require experimental validation.
Language: English
Subfield: Drug Discovery
Open Access status: gold
Estimated APC paid: $2,654
OpenAlex ID: W7234585490
FWCI:
Cites: 55
Cited by:
Related to: 10